Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Key facts

Sponsor

St. Jude Children's Research Hospital

Principal Investigator

John T. Sandlund, MD

St. Jude Children's Research Hospital

Intervention

vinblastine, vincristine, prednisone, daunorubicin(drug)

Enrollment

6 enrolled

Eligibility

10 years · All sexes

Timeline

2002 – 2013

Study locations (1)

• St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Collaborators

Children's Hospital of Philadelphia · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →